Home > Boards > US OTC > Medical - Healthcare > InVivo Therapeutics Holdings Corp (NVIV)

Thanks RottenT. The press release says Q2

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
tomhilsen Member Profile
 
Followed By 1
Posts 256
Boards Moderated 0
Alias Born 07/08/13
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/27/2019 7:42:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/27/2019 7:40:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/27/2019 7:39:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2019 4:31:36 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2019 8:02:28 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2019 4:30:59 PM
InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord Business Wire - 7/16/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/12/2019 8:12:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/12/2019 8:06:17 AM
InVivo Therapeutics Announces Postponement of Annual Meeting Business Wire - 7/12/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/5/2019 8:01:02 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/1/2019 6:00:53 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/21/2019 4:08:00 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 6/21/2019 8:02:13 AM
InVivo Therapeutics gibt Vertagung der Hauptversammlung bekannt Business Wire - 6/14/2019 1:21:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 8:06:21 AM
InVivo Therapeutics Announces Adjournment of Annual Meeting Business Wire - 6/14/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/14/2019 7:51:21 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/5/2019 8:10:45 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/5/2019 8:07:49 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/30/2019 6:01:28 AM
InVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal C... Business Wire - 5/29/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/22/2019 5:56:59 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 5/17/2019 4:37:53 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 8:03:06 AM
tomhilsen   Wednesday, 04/10/19 10:54:55 AM
Re: None
Post # of 6120 
Thanks RottenT. The press release says Q2 2019 is when actual patient enrollments could start. That is around now. The date of press release is April’s Fools Day however.

I am looking forward to the next stage when we could be adding stem cells to assist in spinal regeneration. We might also add nerve growth factors. I do not think we have direct competition doing spinal chord regeneration.




Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist